je.st
news
Genzyme Receives Complete Response Letter from FDA on Lemtradaa (alemtuzumab) Application
2013-12-30 08:58:17| Biotech - Topix.net
Genzyme , a Sanofi company , announced today that it has received a Complete Response Letter from the U.S. Food and Drug Administration for its supplemental Biologics License Application seeking approval of Lemtrada for the treatment of relapsing forms of multiple sclerosis.
Tags: complete
application
response
letter
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||